DLEU2 and hepatocellular carcinoma: Deleted in lymphocytic leukemia 2 (DLEU2) was able to directly interact with Hepatitis B protein and enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2), leading to transcriptional activation of a subset of genes related to hepatocellular carcinoma [27].